Oligopeptide-mediated acceleration of amyloid fibril formation of amyloid β(Aβ) and α-synuclein fragment peptide (NAC)

Journal of Peptide Science

Volumn 10, Issue 1, 2004, Pages 8-17

  Kuroda, Yoshihiro ^a   Maeda, Yoshitaka ^a   Hanaoka, Hirofumi ^a   Miyamoto, Kazuhide ^a   Nakagawa, Terumichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

synuclein; Alzheimer's disease; Amyloid ; Amyloid fibril; Circular dichroism (CD ); Fluorescence spectra; NAC; Oligopeptide; Parkinson's disease; Thioflavine T

Indexed keywords

ALPHA SYNUCLEIN; AMINO ACID; AMYLOID; AMYLOID BETA PROTEIN; BUFFER; HEXAFLUORO 2 PROPANOL; ISOTONIC SOLUTION; OLIGOPEPTIDE; PEPTIDE DERIVATIVE; PHOSPHATE; SODIUM NITRITE; THIOFLAVINE; TRIFLUOROETHANOL; WATER;

ACIDITY; ALPHA HELIX; ARTICLE; BETA SHEET; CIRCULAR DICHROISM; CONTROLLED STUDY; FLUORESCENCE SPECTROSCOPY; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECONDARY STRUCTURE; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ALPHA-SYNUCLEIN; AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN; CIRCULAR DICHROISM; NERVE TISSUE PROTEINS; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; SYNUCLEINS;

EID: 0346505543     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.485     Document Type: Article

References (22)

1. Uéda K, Fukushima H, Masliah E, Xia Y, Iwai A, Yoshimoto M, Otero DAC, Kondo J, Ihara Y, Saitoh T. Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA 1993; 90: 11282-11286.
2. Uéda K, Saitoh T, Mori H. Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non- Aβ component of Alzheimer's disease amyloid. Biochem. Biophys. Res. Commun. 1994; 205: 1366-1372.
3. Yoshimoto M, Iwai A, Kang D, Otero DAC, Xia Y, Saitoh T. NACP, the precursor protein of the non-amyloid β/A4 protein (Aβ) component of Alzheimer disease amyloid, binds Aβ and stimulates Aβ aggregation. Proc. Natl. Acad. Sci. USA 1995; 92: 9141-9145.
4. Jensen PH, Højrup P, Hager H, Nielsen MS, Jacobsen L, Olesen OF, Gliemann J, Jakes R. Binding of Aβ to α- and β-synucleins: identification of segments in α-synuclein/NAC precursor that bind Aβ and NAC. Biochem. J. 1997; 323: 539-546.
5. Iwai A. Properties of NACP/α-synuclein and its role in Alzheimer's disease. Biochim. Biophys. Acta 2000; 1502: 95-109.
6. Serpell LC. Alzheimer's amyloid fibrils: structure and assembly. Biochim. Biophys. Acta 2000; 1502: 16-30.
7. Soto C, Castano EM, Frangione B, Inestrosa NC. The α-helical to β-strand transition in the amino-terminal fragment of the amyloid β-peptide modulates amyloid formation. J. Biol. Chem. 1995; 270: 3063-3067.
8. Ghanta J, Shen C-L, Kiessling LL, Murphy RM. A strategy for designing inhibitors of β-amyloid toxicity. J. Biol. Chem. 1996; 271: 29525-29528.
9. Soto C, Kindy MS, Baumann M, Frangione B. Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation. Biochem. Biophys. Res. Commun. 1996; 226: 672-680.
10. Pallitto MM, Ghanta J, Heinzelman P, Kiessling LL, Murphy RM. Recognition sequence design for peptidyl modulators of β-amyloid aggregation and toxicity. Biochemistry 1999; 38: 3570-3578.
11. Soto C. Plaque busters: strategies to inhibit amyloid formation in Alzheimer's disease. Mol. Med. Today 1999; 5: 343-350.
12. Soto C. Protein misfolding and disease; protein refolding and therapy. FEBS Lett. 2001; 498: 204-207.
13. Kuroda Y, Maeda Y, Nakagawa T. Oligopeptide-mediated stabilization of the α-helix of a prion protein peptide. J. Am. Chem. Soc. 2000; 122: 12 596-12 597.
14. 1H-NMR and circular dichroism spectroscopic studies on changes in secondary structures of the sodium channel inactivation gate peptides as caused by the pentapeptide KIFMK. Biophys. J. 1999; 77: 1363-1373.
15. Wu C-SC, Ikeda K, Yang JT. Ordered conformation of polypeptides and proteins in acidic dodecyl sulfate solution. Biochemistry 1981; 20: 566-570.
16. Sreerama N, Venyaminov SY, Woody RW. Estimation of protein secondary structure from circular dichroism. spectra: inclusion of denatured proteins with native proteins in the analysis. Anal. Biochem. 2000; 287: 243-251.
17. Sreerama N, Woody RW. Estimation of protein secondary structure from circular dichroism spectra: comparison of CONTIN, SELCON, and CDSSTR methods with an expanded reference set. Anal. Biochem. 2000; 287: 252-260.
18. LeVine III H. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: detection of amyloid aggregation in solution. Protein Sci. 1993; 2: 404-410.
19. El-Agnaf OMA, Bodles AM, Guthrie DJS, Harriott P, Irvine GB. The N-terminal region of non-Aβ component of Alzheimer's disease amyloid is responsible for its tendency to assume β-sheet and aggregate to form fibrils. Eur. J. Biochem. 1998; 258: 157-163.
20. Barrow CJ, Yasuda A, Kenny PTM, Zagorski MG. Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease. J. Mol. Biol. 1992; 225: 1075-1093.
21. Han H, Weinreb PH, Lansbury PT. The core of Alzheimer's peptide NAC forms amyloid fibrils which seed and are seeded by β-amyloid: is NAC a common trigger or target in neurodegenerative disease? Chem. Biol. 1995; 2: 163-169.
22. Heintz N, Zoghbi H. α-Synuclein - a link between Parkinson and Alzheimer diseases? Nature Genet. 1997; 16: 325-327.